Impact of atherosclerosis risk factors on the clinical presentation of arterial occlusive disease in Arabic patients

International Journal of Angiology

Volumn 17, Issue 4, 2008, Pages 203-206

  Elsharawy, Mohamed A ^a   Alkhadra, Akram H ^a   Ibrahim, Mohammed Fakhary A ^a   Selim, Fathi ^a   Hassan, Khairy ^a   Elsaid, Aymen S ^a   Bahnassy, Ahmed ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Arabs; Atherosclerosis; Risk factors

Indexed keywords

EID: 79955434113     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278310     Document Type: Article

References (21)

1. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences. Eur Heart J 2004;25:1197-207. (Pubitemid 38891569)
2. Wattanakit K, Folsom AR, Selvin E, et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2005;180:389-97. (Pubitemid 41072911)
3. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2001. Circulation 2004;10:738-43. (Pubitemid 39056275)
4. Hooi JD, Kester AD, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus JA. Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: A longitudinal study. Am J Epidemiol 2001;153:666-72. (Pubitemid 32250974)
5. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996;25:282-90. (Pubitemid 26137108)
6. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997;26:517-38. (Pubitemid 27408567)
7. The World Health Report. Reducing risks, promoting healthy lives. World Health Organization. Geneva (Switzerland); 2002.
8. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504. (Pubitemid 27216360)
9. Bhatt DL, Steg PG, Ohman EM, et al; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9. sumary There are positive correlations among some risk factors of atherosclerosis, and the extent and presentation of atherosclerotic disease in different arterial systems. Aggressive treatment of such risk factors can result in regression of atherosclerosis (20) and can diminish the incidence of cardiovascular events (21). (Pubitemid 43076437)
10. Steg PG, Bhatt DL, Wilson PW, et al; REACH Registry Investigators. One year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-206. (Pubitemid 46465728)
11. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case control study. Lancet 2004;364:937-52. (Pubitemid 39208455)
12. Guijarro C, Mesa N, Jiménez J, et al; AIRVAG Study Researchers. Similarities and differences among patients with symptomatic atherosclerosis affecting several territories. The AIRVAG cohort (Integral Attention to Global Vascular Risk). Med Clin (Barc) 2006;28:605-11. (Pubitemid 44902119)
13. Al Sheikh SO, Aljabri BA, Al Ansary LA, Al Khayal LA, Al Salman MM, Al Omran MA. Prevalence of and risk factors for peripheral arterial disease in Saudi Arabia. A pilot cross-sectional study. Saudi Med J 2007;28:412-4. (Pubitemid 46605064)
14. Chen K, Lindsey JB, Khera A, et al. Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: Observations from the Dallas Heart Study. Diab Vasc Dis Res 2008;5:96-101. (Pubitemid 351839280)
15. Wong ND, Sciammarella MG, Polk D, et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003;7:1547-53. (Pubitemid 36543374)
16. Kallio M, Forsblom C, Groop PH, Groop L, Lepäntalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care 2003;26:1241-5. (Pubitemid 36929279)
17. Missault L, Krygier C, Lukito G, Mary-Rabine L; OPERA Investigators Study Group. Occurrence of peripheral arterial disease in a Belgian cohort of patients with cardiovascular history of atherothrombosis. Acta Chir Belg 2007;107:508-14.
18. Milio G, Corrado E, Sorrentino D, et al. Asymptomatic carotid lesions and aging: Role of hypertension and other traditional and emerging risk factors. Arch Med Res 2006;37:342-7.
19. Landmesser U, Hornig B, Drexler H., Endothelial function: A critical determinant in atherosclerosis? Circulation 2004;109:27-33.
20. Nissen SE, Nicholls SJ, Sipahi I, et al; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006;295:1556-65.
21. Scheen AJ. Clinical study of the month: ASTEROID: Regression of coronary atherosclerosis with rosuvastatin at a maximal daily dose of 40 mg. Rev Med Liege 2006;61:267-72